---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-114096"
form_type: "8-K"
ticker: "CALC"
cik: "0001534133"
company_name: "CalciMedica, Inc."
filed_at: "2026-03-18T23:59:59+00:00"
generated_at: "2026-05-15T09:51:03.972096+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# CalciMedica receives Nasdaq delisting notices for MVLS and bid price deficiencies

## Summary
- Nasdaq notified CalciMedica on Mar 13, 2026 that MVLS was below $35M for 30 consecutive business days.
- Second notice on Mar 16, 2026 for bid price <$1.00 per share for 30 consecutive business days.
- Company has until Sep 9, 2026 (MVLS) and Sep 14, 2026 (bid price) to regain compliance.
- To regain compliance, stock must close at $35M+ for 10 consecutive days (MVLS) or $1.00+ for 10 days (bid price).
- Company says no immediate effect on listing; considering options including reverse stock split.

## SEC filing metadata
- accession: 0001193125-26-114096
- form_type: 8-K
- ticker: CALC
- cik: 0001534133
- company_name: CalciMedica, Inc.
- filed_at: 2026-03-18T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1534133/000119312526114096/0001193125-26-114096-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1534133/000119312526114096/d101411d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-114096
- JSON: https://secwatch.observer/filing/0001193125-26-114096.json
- Plain text: https://secwatch.observer/filing/0001193125-26-114096.txt

## Source-grounded claims
- claim_id: 657252b836158171a45e88195c1980502dc12fc5
  claim: CalciMedica, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).
  evidence_excerpt: March 16, 2026, the Company received a notice from Nasdaq that the Company is not in compliance with Nasdaq’s Listing Rule 5550(a)(2), as the minimum bid price of the Company’s common stock had been below $1.00 per share for 30 consecutive business days (the “Minimum Bid Price Requirement”). Under Nasdaq Listing Rule 5810(c)(3)(A), the Company has 180 calendar days following the date of the notice, or until September 14, 2026, to regain compliance with the Minimum Bid Price Requirement. To regain compliance, the minimum bid price of the Company’s common stock must meet or exceed $1.00 per shar
  evidence_url: https://www.sec.gov/Archives/edgar/data/1534133/000119312526114096/0001193125-26-114096-index.htm
- claim_id: d7211007a4b66380913e5fa5d03a3c694c152b93
  claim: CalciMedica, Inc. received a nasdaq deficiency notice notice regarding market value (rules 5550(b)(2), 5550(b)(1), 5550(b)(3)).
  evidence_excerpt: March 13, 2026, CalciMedica, Inc. (the “Company”) received notice (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) that the Company is not in compliance with Nasdaq’s Listing Rule 5550(b)(2), as the market value of listed securities (the “MVLS Requirement”) for the Company’s common stock had been below the minimum MVLS Requirement of $35,000,000 for the last 30 consecutive business days. Nasdaq also noted that the Company does not meet the requirements under Listing Rules 5550(b)(1) and 5550(b)(3). Under Nasdaq Listing Rule 5810(c)(3)(C), the Company has 180 calendar days following t
  evidence_url: https://www.sec.gov/Archives/edgar/data/1534133/000119312526114096/0001193125-26-114096-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.